Eli Lilly lowers insulin costs as coronavirus crisis deepens
Drugmaker Eli Lilly & Co said on
Tuesday it has capped the out-of-pocket cost for insulin to $35
per month to help diabetes patients across the United States,
many of whom are facing financial difficulties due to the
coronavirus outbreak.
Tuesday it has capped the out-of-pocket cost for insulin to $35
per month to help diabetes patients across the United States,
many of whom are facing financial difficulties due to the
coronavirus outbreak.
Posted by Reuters